N6-methyladenosine in myeloid cells: a novel regulatory factor for inflammation-related diseases.

N6-methyladenosine (m6A) is one of the most abundant epitranscriptomic modifications on eukaryotic mRNA. Evidence has highlighted that m6A is altered in response to inflammation-related factors and it is closely associated with various inflammation-related diseases. Multiple subpopulations of myeloid cells, such as macrophages, dendritic cells, and granulocytes, are crucial for the regulating of immune process in inflammation-related diseases. Recent studies have revealed that m6A plays an important regulatory role in the functional of multiple myeloid cells. In this review, we comprehensively summarize the function of m6A modification in myeloid cells from the perspective of myeloid cell production, activation, polarization, and migration. Furthermore, we discuss how m6A-mediated myeloid cell function affects the progression of inflammation-related diseases, including autoimmune diseases, chronic metabolic diseases, and malignant tumors. Finally, we discuss the challenges encountered in the study of m6A in myeloid cells, intended to provide a new direction for the study of the pathogenesis of inflammation-related diseases. © 2023. The Author(s) under exclusive licence to University of Navarra.

Citation

Jin Pang, Tong-Dong Kuang, Xin-Yuan Yu, Petr Novák, Yuan Long, Min Liu, Wei-Qian Deng, Xiao Zhu, Kai Yin. N6-methyladenosine in myeloid cells: a novel regulatory factor for inflammation-related diseases. Journal of physiology and biochemistry. 2024 May;80(2):249-260

Mesh Tags

Substances

PMID: 38158555

search → result